Fuller & Thaler Asset Management, Inc. Meridian Bioscience Inc Transaction History

Fuller & Thaler Asset Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$31.15 - $33.39 $402,333 - $431,265	-12,916 Reduced 2.4%	524,904 $17.4 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $168,374 - $182,813	-5,449 Reduced 1.0%	537,820 $17 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $2.01 Million - $2.68 Million	84,492 Added 18.42%	543,269 $16.5 Million
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $62,146 - $83,837	3,112 Added 0.68%	458,777 $11.9 Million
Q4 2021 Feb 09, 2022	BUY	$17.46 - $21.61 $4.48 Million - $5.55 Million	256,729 Added 129.05%	455,665 $9.3 Million
Q3 2021 Nov 10, 2021	SELL	$17.35 - $22.5 $26 Million - $33.7 Million	-1,496,815 Reduced 88.27%	198,936 $3.83 Million
Q2 2021 Aug 13, 2021	BUY	$18.01 - $28.32 $978,861 - $1.54 Million	54,351 Added 3.31%	1,695,751 $37.6 Million
Q1 2021 May 13, 2021	BUY	$19.76 - $29.89 $1.2 Million - $1.81 Million	60,583 Added 3.83%	1,641,400 $43.1 Million
Q4 2020 Feb 11, 2021	BUY	$15.73 - $21.66 $6.09 Million - $8.39 Million	387,466 Added 32.47%	1,580,817 $29.5 Million
Q3 2020 Nov 09, 2020	BUY	$13.54 - $26.41 $1.25 Million - $2.44 Million	92,288 Added 8.38%	1,193,351 $20.3 Million
Q2 2020 Aug 13, 2020	BUY	$7.84 - $23.29 $8.62 Million - $25.6 Million	1,099,413 Added 66631.09%	1,101,063 $25.6 Million
Q4 2017 Feb 12, 2018	BUY	$13.55 - $15.8 $8,130 - $9,480	600 Added 57.14%	1,650 $23,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,050	1,050 $17,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.